These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28606406)

  • 1. [Quality of life in patients with autosomal dominant polycystic kidney disease].
    Lecardeur L; Joly D
    Nephrol Ther; 2017 Dec; 13(7):505-510. PubMed ID: 28606406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
    Noël N; Rieu P
    Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review.
    Ebrahimi N; Garimella PS; Chebib FT; Sparks MA; Lerma EV; Golsorkhi M; Ghozloujeh ZG; Abdipour A; Norouzi S
    Kidney360; 2024 Aug; 5(8):1200-1206. PubMed ID: 38976329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychonephrology: psychological aspects in autosomal dominant polycystic kidney disease.
    Pérez Domínguez TS; Rodríguez Pérez A; Buset Ríos N; Rodríguez Esparragón F; García Bello MA; Pérez Borges P; Parodis López Y; Rodríguez Pérez JC;
    Nefrologia; 2011; 31(6):716-22. PubMed ID: 22130288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk for New-Onset Diabetes Mellitus after Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.
    Cheungpasitporn W; Thongprayoon C; Vijayvargiya P; Anthanont P; Erickson SB
    Can J Diabetes; 2016 Dec; 40(6):521-528. PubMed ID: 27184299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.
    Simms RJ; Thong KM; Dworschak GC; Ong AC
    Nephrol Dial Transplant; 2016 Jul; 31(7):1130-40. PubMed ID: 26268712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.
    Joly D; Quinn J; Mokiou S; O'Reilly K; Sánchez-Covisa J; Wang-Silvanto J; Doll H
    BMC Nephrol; 2020 Jul; 21(1):298. PubMed ID: 32709218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychological Assessment of a sample of women with ADPKD: quality of life, body image, anxiety and depression].
    Delli Zotti GB; Sangiovanni E; Brioni E; Ratti MM; Sciarrone Aliprandi MT; Spotti D; Manunta P; Sarno L
    G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
    Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
    Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
    Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
    Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycystic kidney disease and kidney transplantation].
    Tillou X; Timsit MO; Sallusto F; Culty T; Verhoest G; Doerfler A; Thuret R; Kleinclauss F;
    Prog Urol; 2016 Nov; 26(15):993-1000. PubMed ID: 27665410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular disorders in autosomal dominant polycystic kidney disease].
    Hamzaoui M; Lamy G; Bellien J; Guerrot D
    Nephrol Ther; 2021 Feb; 17(1):18-29. PubMed ID: 33431311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autosomal dominant polycystic kidney disease: is the treatment for tomorrow?].
    Cornec-Le Gall E; Le Meur Y
    Nephrol Ther; 2014 Nov; 10(6):433-40. PubMed ID: 25086476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
    Rizk D; Jurkovitz C; Veledar E; Bagby S; Baumgarten DA; Rahbari-Oskoui F; Steinman T; Chapman AB
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):560-6. PubMed ID: 19261830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.
    Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C
    Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research.
    Tong A; Rangan GK; Ruospo M; Saglimbene V; Strippoli GF; Palmer SC; Tunnicliffe DJ; Craig JC
    Nephrol Dial Transplant; 2015 May; 30(5):790-800. PubMed ID: 25637642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant polycystic kidney disease: a case study.
    Phillips A
    Nephrol Nurs J; 2009; 36(1):41-7. PubMed ID: 19271623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of Illness, Satisfaction with Life, and Emotional Control in the Early Stage of Autosomal Dominant Polycystic Kidney Disease.
    Jankowska M; Walerzak A; Harciarek M; Rutkowski B; Dębska-Ślizień A
    Nephron; 2024; 148(4):224-229. PubMed ID: 36223732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening and management of intracranial aneurisms in patients with autosomal dominant polycystic kidney disease].
    Flahault A; Knebelmann B; Nataf F; Trystram D; Grünfeld JP; Joly D
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S147-S153. PubMed ID: 28577737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.